NOA rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

rizatriptan benzoate

Għamla farmaċewtika:

Tablet, orally disintegrating

Kompożizzjoni:

Excipient Ingredients: crospovidone; calcium silicate; aspartame; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; mannitol; Flavour

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

3, 6, 2

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

NOA is indicated for the acute treatment of migraine attacks with or without aura.

Sommarju tal-prodott:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-02-19